Filter Options | ||||||
---|---|---|---|---|---|---|
Public title |
Verify status |
Pay status |
||||
Study ailment |
Study type |
Study phase |
||||
Applicant |
Study leader |
Primary sponsor |
||||
Countries of recruitment and research settings |
|
|||||
More Options |
Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
---|---|---|---|---|---|---|---|
12345 |
North District, The First Affiliated Hospital of Anhui Medical University (Anhui Provincial Public Health Clinical Center) |
Esophageal Cancer |
Therapy Study |
Post-market |
2024-03-24 | 494 | Patient list |
ChiCTR2200066726 |
Affiliated Hospital of North Sichuan Medical College |
esophageal cancer |
Therapy Study |
|
2023-05-12 | 708 | Patient list |
ChiCTR2100051846 |
Affiliated Hospital of Southwest Medical University |
Esophageal cancer |
Therapy Study |
|
2021-11-14 | 894 | Patient list |
ChiCTR2100048917 |
Neoadjuvant PD-1 inhibitor plus chemotherapy in resectable esophageal cancer Department of Thoracic Surgery,Tangdu Hospital, Air Force Medical University |
resectable esophageal cancer |
Therapy Study |
Post-market |
2021-07-24 | 1104 | Patient list |
ChiCTR2000034996 |
using organoid to simulate and study the pathogenesis of esophageal cancer west china hospital of sichuan university |
esophageal precancerous lesion and esophageal cancer |
Therapy Study |
Premarket |
2020-07-26 | 1292 | Patient list |
ChiCTR2000034294 |
Sun Yat-sen University Cancer Center |
Esophageal cancer |
|
|
2020-07-01 | 1395 | Patient list |
ChiCTR2000031971 |
West China Hospital, Sichuan University |
Esophageal cancer |
Therapy Study |
|
2020-04-20 | 1302 | Patient list |
ChiCTR2000030111 |
|
esophageal cancer |
Therapy Study |
Post-market |
2020-02-23 | 1195 | Patient list |
ChiCTR2000029807 |
Combination of Camrelizumab and Neoadjuvant Chemotherapy in Esophageal Cancer Sun Yat-Sen University Cancer Center |
Esophageal Cancer |
Therapy Study |
|
2020-02-21 | 1457 | Patient list |
ChiCTR1900022797 |
Henan Provincal Chest Hospital |
esophageal cancer |
Therapy Study |
Post-market |
2019-06-03 | 1200 | Patient list |